Dr. Agarwals Eye Hospital Completes Amalgamation Process

Effective Date: November 1, 2026
Record Date: November 18, 2026

Reader Takeaway: The company dissolves into Dr. Agarwals Health Care; shareholders get new stock based on the 23:2 exchange ratio.

What just happened

Dr. Agarwals Eye Hospital Limited has officially finalized its scheme of amalgamation with Dr. Agarwals Health Care Limited. Following the sanction from the National Company Law Tribunal (NCLT) dated September 30, 2026, and the subsequent ROC filing on October 14, 2026, the company has confirmed all conditions for the merger are now satisfied.

Why this matters

The company will cease to exist as a separate legal entity on the effective date of November 1, 2026. As a result, the Board of Directors will be dissolved, and the entity will be marked as 'Amalgamated' in official records. This marks the end of the corporate identity of the transferor company, transitioning operations entirely under the transferee entity.

Share Exchange Details

Shareholders who hold equity in Dr. Agarwals Eye Hospital Limited as of the record date—November 18, 2026—will be entitled to shares in Dr. Agarwals Health Care Limited. The approved exchange ratio is 23 fully paid-up equity shares (face value ₹1) of the transferee company for every 2 fully paid-up equity shares (face value ₹10) currently held.

What to track next

Investors should look for further official updates regarding the timeline for the actual credit of the new shares into their demat accounts following the record date. No further action is required for the dissolution of the transferor company, as it is a legal process governed by the NCLT-sanctioned scheme.